Study of Medication and Placebo Response in Major Depression
Phase 4
Completed
- Conditions
- Depressive Disorder, Major
- Registration Number
- NCT00229476
- Lead Sponsor
- University of California, Los Angeles
- Brief Summary
The primary purpose of the research study is to use recordings of brain electrical activity (through electroencephalogram, or EEG) and symptom measurements to determine whether patients are likely to show a response to medication or placebo treatment during a treatment trial for depression.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Clinical Diagnosis of Unipolar Major Depression
Exclusion Criteria
- Substance Abuse, Psychotic Disorder, History of Severe Head Trauma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method depressive symptoms
- Secondary Outcome Measures
Name Time Method brain electrical activity (EEG)
Trial Locations
- Locations (1)
UCLA Neuropsychiatric Institute & Hospital
🇺🇸Los Angeles, California, United States